Androgen Replacement Therapy Market, by Product Type, by Active Ingredient Type, by Distribution Channel,A and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy, in which androgens, often testosterone, are replaced. ART is often prescribed to counter the effects of male hypogonadism. It typically involves the administration of testosterone through injections, skin creams, patches, gels, or subcutaneous pellets. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level. Furthermore, benefits related to application of testosterone replacement therapy include an increase in muscle tissue, overall surge in energy, and significant decrease in depression symptoms.

Market Dynamics

The androgen replacement therapy market is expected to witness growth during the forecast period, owing to the increasing number of product launches in the market. For instance, n November 2018, Antares Pharma, Inc. announced the commercial launch of XYOSTED, a subcutaneous injection of testosterone enanthate. XYOSTED was launched in three dosage strengths, 50 mg, 75 mg and 100 mg and is indicated for testosterone replacement therapy.

Key players are entering long term collaborations and agreements, which is expected to propel growth of the global androgen replacement therapy market during the forecast period. For instance, in June 2019, AbbVie, Inc. acquired Allergan, a global pharmaceutical company, in a cash and stock transaction for a transaction equity value of around US$ 63 billion, based on the closing price of AbbVie's common stock of US$ 78.45 on June 24, 2019. As a result of this acquisition, Abbivie, Inc. enhanced its long-term R&D funding capacity, allowing for continued investment and expand its product portfolio.

However, the side effects caused due to androgen replacement therapy are expected to hamper the androgen replacement therapy market growth. The side effects from the androgen replacement therapy include chest pain, shortness of breath or trouble breathing, weakness in one part or one side of the body, slurred speech, sleep apnea, increased cholesterol levels, and increased blood pressure. For instance, in 2015, the U.S. FDA issued a warning about potential cardiovascular risks such as heart attack and stroke resulting from testosterone therapy.

Key features of the study:

This report provides an in-depth analysis of global androgen replacement therapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global androgen replacement therapy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company, Kyowa Kirin International Plc., Novartis International AG, Pfizer Inc., Clarus Therapeutics, Inc., Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Sawai pharmaceutical Co., Ltd., Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., and Simple Pharma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global androgen replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the androgen replacement therapy market

Detailed Segmentation:

Global Androgen Replacement Therapy Market, By Product Type:
- Testosterone Creams/Gels
- Testosterone Patches
- Testosterone Injections
- Testosterone Implants
- Testosterone Tablets/Capsules/Gums
Global Androgen Replacement Therapy Market, By Active Ingredient Type:
- Testosterone
- Methyl Testosterone
- Testosterone Undecanoate
- Testosterone Enanthate
- Testosterone Cypionate
Global Androgen Replacement Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Androgen Replacement Therapy Market, By Region:
- North America
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
- Middle East
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Product Type:
  - Testosterone Creams/Gels
  - Testosterone Patches
  - Testosterone Injections
  - Testosterone Implants
  - Testosterone Tablets/Capsules/Gums
  - By Active Ingredient Type:
  - Testosterone
  - Methyl Testosterone
  - Testosterone Undecanoate
  - Testosterone Enanthate
  - Testosterone Cypionate
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- AbbVie, Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bayer AG
- Endo Pharmaceuticals, Plc.
- Eli Lilly and Company
- Kyowa Kirin International Plc.
- Novartis International AG
- Pfizer Inc.
- Clarus Therapeutics, Inc.
- Perrigo Company Plc
- Acerus Pharmaceuticals Corporation
- Sawai pharmaceutical Co., Ltd.
- Reddy's Laboratories
- Sun Pharmaceutical Industries Ltd.
- Simple Pharma

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3787

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Active Ingredient Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Reimbursement Scenario
New Product Launches/Approvals
Collaborations & Partnerships
Mergers & Acquisitions
PEST Analysis

4. Global Androgen Replacement Therapy Market, By Product Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Creams/Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Oral Tablets/Capsules/Gums
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Androgen Replacement Therapy Market, By Active Ingredient Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Methyl Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Testosterone Undecanoate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Testosterone Enanthate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Testosterone Cypionate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Androgen Replacement Therapy Market, By Distribution Channel, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Androgen Replacement Therapy Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Active Ingredient Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

8. Competitive Landscape

Company Profiles
- AbbVie, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Endo Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Kyowa Kirin International Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Clarus Therapeutics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ferring Holding SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Perrigo Company Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Acerus Pharmaceuticals Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Upsher-Smith Laboratories, LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bausch Health Companies Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Par Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies

9. Section

References
Research Methodology
About Us and Sales Contact

Androgen Replacement Therapy Market, by Product Type, by Active Ingredient Type, by Distribution Channel,A and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028